4880

LIVE

Serial Number

97613272

Owner

Mallinckrodt Pharmaceuticals Ireland Limited

Attorney

Camille M. Miller

First Use Date

Mar 7, 2024

Filing Date

Sep 29, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

4880 Trademark

Serial Number: 97613272 • Registration: 7986110

4880 is a trademark filed by Mallinckrodt Pharmaceuticals Ireland Limited on September 29, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Mallinckrodt Pharmaceuticals Ireland Limited (7 trademarks)

College Business & Technology Park
Blanchardstown, Dublin 15 D15 TX2V , IE

Entity Type: 77

Legal Representation

Attorney of Record

Camille M. Miller

6,736 trademarks filed View all →

Correspondence Address

Camille M. Miller Cozen O'Connor

1650 Market Street, Suite 2800

Philadelphia, PA 19103

United States

Trademark Details

Filing Date

September 29, 2022

Registration Date

October 14, 2025

First Use Anywhere

March 7, 2024

First Use in Commerce

March 7, 2024

Published for Opposition

November 14, 2023

Goods & Services

Pharmaceutical preparations, namely, nitric oxide for inhalation for treating pulmonary hypertension and conditions associated with pulmonary hypertension

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 13, 2026 TCCA

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Mar 13, 2026 ECDR

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 13, 2026 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 13, 2026 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Mar 13, 2026 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Mar 13, 2026 COAR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 14, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Oct 14, 2025 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 23, 2025 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 23, 2025 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Sep 20, 2025 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 20, 2025 AITU

USE AMENDMENT FILED

Apr 28, 2025 IUAF

TEAS STATEMENT OF USE RECEIVED

Apr 28, 2025 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 3, 2025 EXRA

SOU EXTENSION 2 GRANTED

Jan 6, 2025 EX2G

SOU EXTENSION 2 FILED

Jan 6, 2025 EXT2

SOU TEAS EXTENSION RECEIVED

Jan 6, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 8, 2024 EXRA

SOU EXTENSION 1 GRANTED

Jul 8, 2024 EX1G

SOU EXTENSION 1 FILED

Jul 8, 2024 EXT1

SOU TEAS EXTENSION RECEIVED

Jul 8, 2024 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jan 9, 2024 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 14, 2023 NPUB

PUBLISHED FOR OPPOSITION

Nov 14, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 25, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 12, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 11, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 11, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 11, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 13, 2023 GNRN

NON-FINAL ACTION E-MAILED

Jul 13, 2023 GNRT

NON-FINAL ACTION WRITTEN

Jul 13, 2023 CNRT

ASSIGNED TO EXAMINER

Jul 13, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 3, 2022 NWOS

NEW APPLICATION ENTERED

Oct 3, 2022 NWAP

Related Trademarks

More from this Owner

KEENOVA CARES

KEENOVA

KEENOVA CARES

KEENOVA CARES COMPASSION. ACCESS. REIMBURSEMENT. EMPOWERMENT. SUPPORT.

KEENOVA THERAPEUTICS

More in Same Class

CITRIVAR

LIFETIME THE LONGEVITY GROUP

COLAGEINA 10

A ALLIANCE FREEZE DRY

NUVICARE

TOTALAID